ASHP Midyear Clinical Meeting & Exhibition

Amanuel Kehasse, PharmD, PhD, explored reasons why patients and providers may be avoiding the implementation of biosimilar medications.

Research found that SGLT2 inhibitors were associated with a lower risk of major cardiovascular events or hospitalization for heart failure.

Ethan Melillo, PharmD, CDOE, senior manager of Integrated Health at L’Oréal, provides some of his favorite recommendations to help with irritated skin.

John Bucheit, PharmD, joined Drug Topics to discuss statins and nonstatins’ efficacy in treating cardiovascular disease.

Denise Kelley, PharmD, BCPS, FASHP, discussed the efficacy of medications designed to treat the progression of chronic kidney disease.

A conversation with Kathleen Vest, PharmD, BCACP, CDCES, FCCP, professor of Pharmacy Practice at Drake University College of Pharmacy and Health Sciences.

Kathryn Litten, PharmD, joined Drug Topics to discuss how pharmacists can counsel patients with metabolic dysfunction-associated steatotic liver disease.

Pharmacists can influence institutional-level climate change-related policies to ensure continued health care delivery.

The effectiveness of remdesivir was consistent among patients who received any form of supplemental oxygen and across all age groups in the study.

Researchers observed the use of a discrete event simulation using non-invasive tests for patients with nonalcoholic steatohepatitis.

A tour of modern antiretroviral and pre-exposure prophylaxis therapies included the latest updates in HIV management and prevention.

Pharmacist inclusion in infectious disease care teams leads to better patient outcomes.

Patients with ASCVD experienced a more significant reduction in LDL-C.

Research also showed that the percentage of no-show appointments was slightly higher in a pre-virtual group compared to a post-virtual group.

Efficacy data for dapagliflozin and empagliflozin in a group of Asian patients were evaluated.

A discussion with Kevin Cowart, PharmD, MPH, BCACP, FCCP, BCPS, assistant professor at the University of South Florida Taneja College of Pharmacy.

John Bucheit, PharmD, discussed lipid-lowering medications and how nonstatins can be beneficial for cardiovascular health.

A discussion with Brittany Norton, PharmD, director of ambulatory care at Sutter Health.

Navigating Cannabis use requires more than just an understanding of the endocannabinoid system.

Two posters presented at ASHP Midyear 2023 explored the impact of diabetes management interventions among patients with diabetes.

Three posters presented at ASHP Midyear 2023 delved deeper into the topic of antimicrobial stewardship programs and their impact on antibiotic resistance.

Two posters presented at ASHP Midyear 2023 looked at how the two medications differed and how clinical pharmacy services improved transitions.

The analysis revealed deeper issues created by payer and manufacturer lockouts placed on Integrated Health System Specialty Pharmacies.

Two posters presented at ASHP 2023 Midyear examined how accurate answers were from the artificial intelligence chatbot.

Investigators developed a new Plan-Do-Study-Act cycle to meet standards of USP <800> at a central-fill pharmacy.

A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.

Increased clinical awareness around the value of lithium monitoring was ultimately achieved.

A study presented at ASHP Midyear 2023 found that primary care physicians said a refill management service helped reduce burnout and improved the quality of patient care.

A Q&A with Lisa McCabe, PharmD, MBA, BSN, director of Health System Pharmacy at Cardinal Health.

Most patients were not concerned about losing control over their disease after switching.